The Core Unit for Molecular Tumor Diagnostics (CMTD) is a research facility for the molecular characterization of sporadic and hereditary tumors based on next generation sequencing (NSG) techniques, bioinformatic analysis pipelines and interpretation of the results by experienced molecular pathologists and human geneticists. It is an essential and fundamental interface in the area of translational cancer research and clinical studies. The aim of the CMTD is the fast translation of novel molecular markers into clinical application by making indication-specific multi gene panels available.
Core Unit for Molecular Tumor Diagnostics
Service features:
Project request:
For a new project please fill in the CMTD request form and send them to: cmtd-service(at)nct-dresden.de
Please keep the project title short and unique for your project. As project description 2-3 short sentences about your project are sufficient. All other fields are optional, but will help us and you for a better planning of your project.
Applications:
Please contact us for consultation prior to sequencing projects. This will allow us to provide initial support in study design and therefore optimize the performance of the NGS experiments.
We offer high-throughput sequencing services, consultation and expert assistance in planning, sample preparation and method development.
Here are a few examples of what we offer:
DNA Sequencing_Panel
- Illumina TruSight Oncology
- Illumina TruSight Tumor 15 Panel
- Illumina TruSight Tumor 170 Panel
- Qiagen Human Comprehensive Cancer Panel
DNA Sequencing_Custom Panel
DNA Sequencing_Exom
Additional methods and support
Contact
Dr. rer. medic Sandra Oster
Coordinator Core Unit for Molecular Tumor Diagnostics
Tel.: +49 (0)351 458 11937
sandra.oster(at)nct-dresden.de
cmtd-service(at)nct-dresden.de
Directors
Prof. Dr. med. Gustavo Baretton
Director of the Institute for Pathology
Co-Director Core Unit for Molecular Tumor Diagnostics
Tel.: +49 (0) 351 458 3000
gustavo.baretton(at)uniklinikum-dresden.de
Prof. Dr. med. Evelin Schröck
Director of the Institute for Clinical Genetics
Co-Director Core Unit for Molecular Tumor Diagnostics
Tel.: +49 (0) 351 458 5136
evelin.schrock@uniklinikum-dresden.de
Coordinators
Prof. Dr. med. Daniela Aust
Medical Coordinator
Institute for Pathology
Tel.: +49 (0)351 458 3004
daniela.aust(at)uniklinikum-dresden.de
Dr. rer. nat. Doreen William
Scientific Coordinator
Head of Molecular Genetic Research of the Institute for Clinical Genetics
Tel.: +49 (0)351 458 13914
Doreen.William(at)uniklinikum-dresden.de
Dr. Sandra Oster
Scientific Coordinator
Core Unit for Molecular Tumor Diagnostic NCT/UCC
Tel.: +49 (0)351 458 11937
sandra.oster@nct-dresden.de
Staff
Dr. rer. nat. Stephan Drukewitz
Bioinformatician
Dr. rer. nat. Anja Kögler
Bioinformatician
Tel.: +49 (0)351 458 11745
anja.kögler@nct-dresden.de
Dr. rer. nat. Thomas Groß
Bioinformatician
Tel.: +49 (0)351 458 11327
thomas.groß(at)nct-dresden.de
PhD Sakshi Singh
Bioinformatician
Tel.: +49 (0)351 458 19904
sakshi.singh(at)nct-dresden.de
Alexander Krüger (MTA)
Tel.: +49 (0)351 458 16857
alexander.krüger(at)nct-dresden.de
Enrico Zyball (MTA)
Tel.: +49 (0)351 458 19621
enrico.zyball(at)nct-dresden.de